Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atherosclerotic Cardiovascular Disease With Dyslipidemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT02726555
What this trial is testing

The Efficacy and Safety of Combined Therapy With Red Yeast Rice and Low-dose Statin：Comparing With Standardized Statin

Who this might be right for
DyslipidemiaAtherosclerosis
Wenzhou Medical University 240
Large-scale testing (Phase 3)Study completedNCT05888103
What this trial is testing

Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.

Who this might be right for
Primary Hypercholesterolemia or Mixed Dyslipidemia
Novartis Pharmaceuticals 207
Early research (Phase 1)Looking for participantsNCT07428473
What this trial is testing

STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)

Who this might be right for
Elevated LDL-C and High Cholesterol
Monash University 64
Post-approval studies (Phase 4)Ended earlyNCT04073134
What this trial is testing

The CHORAL Flow Study

Who this might be right for
Coronary Artery DiseaseAtherosclerosisHyperlipidemias
Imperial College London 12
Not applicableActive Not RecruitingNCT06832371
What this trial is testing

Evaluation of the Effect of Lomitapide Treatment on Major Adverse Cardiovascular Events (MACE) in Patients With Homozygous Familial Hypercholesterolemia

Who this might be right for
Homozygous Familial Hypercholesterolemia (HoFH)Major Adverse Cardiovascular Events (MACE)Dyslipidemia
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) 73
Post-approval studies (Phase 4)Study completedNCT00651274
What this trial is testing

Comparison of Co-administration of Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Primary Hypercholesterolemia (P03476)

Who this might be right for
AtherosclerosisHypercholesterolemiaCoronary Heart Disease
Organon and Co 144
Testing effectiveness (Phase 2)Study completedNCT00474864
What this trial is testing

Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia.

Who this might be right for
Healthy SubjectsDyslipidaemiasDyslipidaemia
GlaxoSmithKline 66
Not applicableUnknownNCT03984149
What this trial is testing

Lipa Gene Mutation in PED-LIPIGEN (Pediatric FH Subjects)

Who this might be right for
Lysosomal Acid Lipase Deficiency
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) 1,000
Not applicableUnknownNCT02489253
What this trial is testing

Atherosclerosis in Familial Hypercholesterolemia

Who this might be right for
Familial Hypercholesterolemia
University College, London 100
Large-scale testing (Phase 3)Study completedNCT06005597
What this trial is testing

Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies

Who this might be right for
DyslipidemiasHypercholesterolemiaFamilial Hypercholesterolemia+2 more
NewAmsterdam Pharma 407
Testing effectiveness (Phase 2)Study completedNCT04770389
What this trial is testing

Randomized Study of Obicetrapib in Combination With Ezetimibe

Who this might be right for
DyslipidemiasHigh CholesterolHypercholesterolemia
NewAmsterdam Pharma 112
Not applicableWithdrawnNCT02399852
What this trial is testing

Effects of Lomitapide on Carotid and Aortic Atherosclerosis

Who this might be right for
Homozygous Familial Hypercholesterolemia
Aegerion Pharmaceuticals, Inc.
Post-approval studies (Phase 4)Not Yet RecruitingNCT07803679
What this trial is testing

A Trial Assessing the Effectiveness of Evolocumab in Reducing the Plaque Burden in Participants With Subclinical Atheroma

Who this might be right for
Coronary Artery DiseaseHypercholesterolemiaAtheroma+1 more
Amgen 308
Early research (Phase 1)Study completedNCT05398029
What this trial is testing

VERVE-101 in Patients With Familial Hypercholesterolemia and Cardiovascular Disease

Who this might be right for
Heterozygous Familial HypercholesterolemiaAtherosclerotic Cardiovascular DiseaseHypercholesterolemia
Verve Therapeutics, Inc. 13
Large-scale testing (Phase 3)Study completedNCT00116870
What this trial is testing

MARS - Monitored Atherosclerosis Regression Study

Who this might be right for
AtherosclerosisCoronary Artery Disease
Merck Sharp & Dohme LLC 270
Not applicableStudy completedNCT00921011
What this trial is testing

Longitudinal Study in Perimenopausal Women With Risk Factors for Atherosclerosis

Who this might be right for
Atherosclerosis
Ohio State University 177
Large-scale testing (Phase 3)Study completedNCT03400800
What this trial is testing

Inclisiran for Subjects With ASCVD or ASCVD-Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol

Who this might be right for
ASCVDRisk Factor, CardiovascularElevated Cholesterol
The Medicines Company 1,617
Large-scale testing (Phase 3)Ended earlyNCT00651391
What this trial is testing

Effect of Ezetimibe Plus Simvastatin on Flow-Mediated Brachial Artery Vasoactivity in Subjects With Primary Hypercholesterolemia (Study P03336)

Who this might be right for
HypercholesterolemiaAtherosclerosis
Organon and Co 28
Post-approval studies (Phase 4)UnknownNCT04306081
What this trial is testing

Effect of Evolocumab in Functional Status and LDL Oxidation of Patients With Peripheral Arterial Disease

Who this might be right for
Peripheral Arterial Disease
Leonardo Clavijo 86
Large-scale testing (Phase 3)Study completedNCT02991118
What this trial is testing

Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk

Who this might be right for
HypercholesterolemiaAtherosclerotic Cardiovascular Disease
Esperion Therapeutics, Inc. 779
Next Page